Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Jun;4(6):827-36.
doi: 10.1517/14712598.4.6.827.

Role of interferons in the treatment of severe acute respiratory syndrome

Jindrich Cinatl Jr  1 , Martin Michaelis, Martin Scholz, Hans Wilhelm Doerr
Affiliations
Review

Role of interferons in the treatment of severe acute respiratory syndrome

Jindrich Cinatl Jr et al. Expert Opin Biol Ther. 2004 Jun.

Abstract

Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus (SCV). The disease appeared in the Guandong province of southern China in 2002. The epidemic affected > 8422 patients and caused 908 deaths in 29 countries on 5 continents. Several treatment modalities were tried with limited success to treat SARS and a variety of experimental drugs are under development. Type I interferons (IFNs-alpha/beta) were suggested as potential candidates to treat SARS. Several animal and human coronaviruses, including SCV, were shown to be sensitive to IFNs both in vitro and in vivo. A pilot clinical report showed effectiveness of IFN-alpha for the treatment of SARS patients. This review summarises antiviral activities of IFNs with special regard to SARS, and reviews the published clinical and experimental data describing the use of IFNs for SARS.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

Bibliography

    1. STADLER K, MASIGNANI V, EICKMANN M et al.: SARS-beginning to understand a new virus. Nat. Rev Microbiol. (2003) 1:209–218. - PMC - PubMed
    1. PEIRIS JS, YUEN KY, OSTERHAUS AD, STOHR K: The severe acute respiratory syndrome. N Engl. J. Med. (2003) 349:2431–2441. - PubMed
    1. VASTAG B: Old drugs for a new bug: influenza, HIV drugs enlisted to fight SARS. JAMA (2003) 290:1695–1696. - PubMed
    1. DAVIDSON A, SIDDELL S: Potential for antiviral treatment of severe acute respiratory syndrome. Carr: Opin. Infect. Dis. (2003) 16:565–571. - PubMed
    1. LEE N, HUI D, WU A et al.: A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl. J. Med. (2003) 348:1986–1994. - PubMed

Websites

    1. http://www.cdc.gov/ncidod/sars/ clinicalguidance.htm CDC guidance and recommendations for SARS .
    1. http://www.who.int/csr/sars/en WHO SARS website .

MeSH terms

LinkOut - more resources